Share chart Vaccinex, Inc.
Extended chart
Simple chart
About Vaccinex, Inc.
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders. The company's lead drug candidate, pepinemab, a humanized monoclonal antibody that binds and blocks the activity of SEMA4D. Its Pepinemab is being evaluated in a Phase 1b/2 study in recurrent or metastatic head and neck cancer and in a Phase 1/2a study in Alzheimer's Disease, with ongoing exploration of potential Phase 3 development in Huntington's disease. more details| IPO date | 2018-08-09 |
|---|---|
| ISIN | US9186401033 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.vaccinex.com |
| Цена ао | 7.55 |
| Change price per day: | -0.9091% (1.1) |
|---|---|
| Change price per week: | -9.92% (1.21) |
| Change price per month: | -70.46% (3.69) |
| Change price per 3 month: | -67.56% (3.36) |
| Change price per half year: | -83.68% (6.68) |
| Change price per year: | -88.29% (9.3072) |
| Change price per 3 year: | -15.5% (1.29) |
| Change price per 5 year: | -77.53% (4.85) |
| Change price per 10 year: | 0% (1.09) |
| Change price per year to date: | -70.46% (3.69) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| AIGH Capital Management LLC | 58362 | 4.74 |
| Worth Venture Partners, LLC | 46720 | 3.79 |
| Vanguard Group Inc | 3444 | 0.28 |
| Renaissance Technologies, LLC | 2293 | 0.19 |
| Two Sigma Investments, LP | 1154 | 0.09 |
| Geode Capital Management, LLC | 1150 | 0.09 |
| XTX Topco Ltd | 838 | 0.07 |
| Tower Research Capital LLC (TRC) | 475 | 0.04 |
| Group One Trading, L.P. | 65 | 0.01 |
| UBS Group AG | 24 | 0 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Dr. Maurice Zauderer Ph.D. | Co-Founder, CEO, President & Director | 411.7k | 1946 (79 years) |
| Dr. Elizabeth E. Evans Ph.D. | COO and Senior VP of Discovery & Translational Medicine | 291.57k | 1973 (52 years) |
| Dr. Ernest S. Smith Ph.D. | Senior VP of Research & Chief Scientific Officer | 297.25k | 1972 (53 years) |
| Dr. John E. Leonard Ph.D. | Senior Vice President of Development | N/A | 1947 (78 years) |
| Ms. Jill Sanchez CPA | Chief Financial Officer | N/A | 1972 (53 years) |
Address: United States, Rochester. NY, 1895 Mount Hope Avenue - open in Google maps, open in Yandex maps
Website: https://www.vaccinex.com
Website: https://www.vaccinex.com
